A Phase 2 Randomized Trial of Chemoradiation with or without Panitumumab in Subjects with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Grants and Contracts Details

StatusFinished
Effective start/end date1/10/089/30/11

Funding

  • AMGen: $35,078.00